Autism And Vaccines – A Major Contributing Factor of Toxins and Infections


More Vaccines – More Autism

·  In 1983, autism rates were 1 in 10,000 and there were 11 vaccines in the pediatric schedule.  Today there are 36 pediatric vaccines and autism rates are reported as high as 1 in 80 in local school districts in Oregon and New Jersey.


The US has the most bloated vaccine schedule

·The average of the top 30 countries is ½ of our vaccine schedule (18 less vaccines).

Vaccines By Country sorted by number of vaccines


In 1989, the vaccine makers were given indemnity

Autism was 1 in 10,000 children and we only used 10 vaccines.




Almost all vaccines are approved for the US pediatric schedule

The main bodies that makes the recommended vaccine schedule is designed to rubber stamp vaccine requests.

  1. There are no individuals that specialize in understanding the potential side effects of vaccines.
    1. There are no toxicological experts on the VRBPAC or the ACIP.
    2. There are no chronic illness experts on the VRBPAC or the ACIP.
  2. The VRBPAC and the ACIP (the two main government body that determines the vaccine schedule) allows members to have ties to the pharmaceutical companies.

Congress Has Found Significant Conflicts of Interest in the VRBPAC and ACIP


Example: Quotes from the government investigation on the Rotovirus vaccine

“Staff Report Details FDA and CDC Conflicts in Approval of Controversial Rotavirus Vaccine”

“A House Government Reform Committee staff report published this week criticized the FDA and the CDC for routinely allowing scientists with conflicts of interest to serve on two influential advisory committees that make recommendations on vaccine policy.”

"It has become clear over the course of this investigation that the VRBPAC and the ACIP [the two main advisory boards that determine the vaccine schedule] are dominated by individuals with close working relationships with the vaccine producers. This was never the intent of the Federal Advisory Committee Act, which requires that a diversity of views be represented on advisory committees."

ACIP Members with Conflicts of Interest Are Allowed On the Board and Can Vote

“3.   ACIP Members are allowed to Vote on Vaccine Recommendations, Even When They Have Financial Ties to Drug Companies Developing Related or Similar Vaccines”

Paul Offit, who has made more than 30 million dollars on the Rotovirus Vaccine, voted his vaccine into the schedule three times.

“b.  Dr. Paul Offit (Exhibits 38-41)”

“Dr. Offit shares the patent on the Rotavirus vaccine in development by Merck and lists a $350,000 grant from Merck for Rotavirus vaccine development. Also, he lists that he is a consultant to Merck. “

“Dr. Offit began his tenure on ACIP in October of 1998.  Out of four votes pertaining to the ACIP’s rotavirus statement he voted “yes” three times, including, voting for the inclusion of the rotavirus vaccine in the VFC program.”

“Dr. Offit abstained from voting on the ACIP’s rescission of the recommendation of the rotavirus vaccine for routine use.  He stated at the meeting, “I’m not conflicted with Wyeth, but because I consult with Merck on the development of rotavirus vaccine, I would still prefer to abstain because it creates a perception of conflict.”[lxvii]”

Rules about conflicts of interest are weak and lax.

Majority Staff Report, Committee on Government Reform, U.S. House of Representatives

June 15, 2000

49 page report available at:

A key quotation:

"Members of the advisory committees are required to disclose any financial conflicts of interest and recuse themselves from participating in decisions in which they have an interest. The Committee’s investigation has determined that conflict of interest rules employed by the FDA and the CDC have been weak, enforcement has been lax, and committee members with substantial ties to pharmaceutical companies have been given waivers to participate in committee proceedings."

Vaccines Can Cause Chronic Illness


Vaccination with the DTP vaccine on schedule led to double the amount of asthma.

Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma.

McDonald KL, Huq SI, Lix LM, Becker AB, Kozyrskyj AL.

Faculty of Medicine, Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

BACKGROUND: Early childhood immunizations have been viewed as promoters of asthma development by stimulating a T(H)2-type immune response or decreasing microbial pressure, which shifts the balance between T(H)1 and T(H)2 immunity. OBJECTIVE: Differing time schedules for childhood immunizations may explain the discrepant findings of an association with asthma reported in observational studies. This research was undertaken to determine whether timing of diphtheria, pertussis, tetanus (DPT) immunization has an effect on the development of childhood asthma by age 7 years. METHODS: This was a retrospective longitudinal study of a cohort of children born in Manitoba in 1995. The complete immunization and health care records of cohort children from birth until age 7 years were available for analysis. The adjusted odds ratio for asthma at age 7 years according to timing of DPT immunization was computed from multivariable logistic regression. RESULTS: Among 11, 531 children who received at least 4 doses of DPT, the risk of asthma was reduced to (1/2) in children whose first dose of DPT was delayed by more than 2 months. The likelihood of asthma in children with delays in all 3 doses was 0.39 (95% CI, 0.18-0.86). CONCLUSION: We found a negative association between delay in administration of the first dose of whole-cell DPT immunization in childhood and the development of asthma; the association was greater with delays in all of the first 3 doses. The mechanism for this phenomenon requires further research.

Vaccinated children had more eczema, asthma hay fever and food allergy

Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and non-vaccinated children.

Bernsen RM, Nagelkerke NJ, Thijs C, van der Wouden JC.

Department of General Practice, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands. [email protected]

Pertussis infection has been suspected to be a potential causal factor in the development of atopic disease because of the effect of pertussis immunization on specific IgE antibodies. Although several studies found a positive association between pertussis infection and atopic disorders, this relationship has not yet been studied in a population stratified by vaccination status. To assess the association between pertussis infection and atopic disorders in pertussis-unvaccinated children and in pertussis-vaccinated children. Using data from a previously conducted study on the relationship between the diphtheria-tetanus-pertussis-(inactivated) poliomyelitis vaccination in the first year of life and atopic disorders, the study population of 1872 8-12 yr old was divided into children pertussis-unvaccinated and children pertussis-vaccinated in the first year of life. Within each group, the association between pertussis infection and atopic disorders (both as reported by the parents) was assessed. In the unvaccinated group, there were no significant associations between pertussis infection and atopic disorders. In the vaccinated group, all associations between pertussis infection and atopic disorders were positive, the associations with asthma [odds ratio (OR) = 2.24, 95% confidence interval (CI(95%)): 1.36-3.70], hay fever (OR = 2.35, CI(95%): 1.46-3.77) and food allergy (OR = 2.68, CI(95%): 1.48-4.85) being significant. There was a positive association between pertussis infection and atopic disorders in the pertussis vaccinated group only. From the present study, it cannot be concluded whether this association is causal or due to reverse causation.

HIB Vaccine can cause type 1 diabetes

Ann N Y Acad Sci. 2003 Nov;1005:404-8

Vaccinations may induce diabetes-related autoantibodies in one-year-old children.


Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J; Abis Study Group.

Division of Pediatrics, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

Vaccinations have been discussed as one among many environmental candidates contributing to the immune process that later may lead to type 1 diabetes. ABIS (All Babies in Southeast Sweden) is a prospective cohort study following a nonselected birth cohort of general population. In a randomly selected sample collection from 4400 children, GADA and IA-2A have been determined at the age of 1 year. The information on vaccinations was collected from questionnaires answered by the parents and was related to beta cell autoantibodies. When studying the induction of autoantibodies using the autoantibody level of 90th percentile as cutoff level, hemophilus influenza B (HIB) vaccination appeared to be a risk factor for IA-2A [OR 5.9 (CI 1.4-24.4; p = 0.01)] and for GADA [OR 3.4 (CI 1.1-10.8; p = 0.04)] in logistic regression analyses. Furthermore, the titers of IA-2A were significantly higher (p < 0.01 in Mann-Whitney test) in those children who had got HIB vaccination. When 99th percentile was used as cutoff to identify the children at risk of type 1 diabetes, BCG vaccination was associated with increased prevalence of IA-2A (p < 0.01). We conclude that HIB vaccination may have an unspecific stimulatory polyclonal effect increasing the production of GADA and IA-2A. This might be of importance under circumstances when the beta cell-related immune response is activated by other mechanisms.

PMID: 14679101

The U.S. Does Not Have Any Toxicologists or Chronic Illness Experts on the VRBPAC or the ACIP


Although vaccines contain neurotoxins and carcinogens, neither the VRBPAC or ACIP have any toxicologists or chronic illness Experts on the committee.

Advisory Committee on Immunization Practices (ACIP)

Committee Membership Roster

January 21, 2009



MORSE, Dale L., M.D., M.S. 

Assistant Commissioner, Office of Science

New York State Department of Health   

Albany, New York

Term: 07/01/05-06/30/09




Senior Advisor to the Director

National Center for Immunization & Respiratory Diseases 

Centers for Disease Control & Prevention  

1600 Clifton Road, NE, Mailstop E-05  

Atlanta, Georgia  30333



BAKER, Carol, M.D.  

Professor of Pediatrics   

Molecular Virology and Microbiology 

Baylor College of Medicine 

Houston, Texas 

Term: 07/01/06-06/30/10


BECK, Robert L., J.D.

Consumer Representative  

Palmyra, Virginia   

Term: 07/01/05-06/30/09


CHILTON, Lance, M.D. 

General Pediatrics and Adolescent Medicine, Young Children's Health Center  

Professor, Department of Pediatrics  

University of New Mexico School of Medicine  

Albuquerque, New Mexico   

Term: 07/01/07-06/30/11


CIESLAK, Paul, M.D.  

Medical Director, Immunization Program &

Program Manager, Acute & Communicable Disease Prevention

Oregon Public Health Division  

Portland, Oregon  

Term: 07/01/07-06/30/11


EHRESMANN, Kristen R.N., M.P.H.,

Section Chief

Immunization, Tuberculosis, and International Health Section

Minnesota Department of Health

St. Paul, Minnesota 

Term:  07/01/2008 - 06/30/2012


ENGLUND, Janet, M.D.

Associate Professor of Pediatrics, University of Washington

Clinical Associate, Fred Hutchinson Cancer Research Center

Division of Inf. Disease, Immunology and Rheumatology  

Children's Hospital and Regional Medical Center

Seattle, Washington

Term: 07/01/07-06/30/11  


JUDSON, Franklyn N., M.D.  

Professor, Departments of Medicine (Infectious Diseases) & Preventive Medicine and Biometrics

University of Colorado Health Sciences Center

Denver, Colorado 

Term: 09/19/07-06/30/11


LETT, Susan M., M.D., M.P.H. 

Medical Director, Immunization Program 

Division of Epidemiology and Immunization Massachusetts Department of Public Health

Jamaica Plain, Massachusetts 

Term: 07/01/06-06/30/10


MARCY, S. Michael, M.D.,

UCLA Center for Vaccine Research 

Harbor-UCLA Medical Center

Torrance, California

Term:  07/01/2008 - 06/30/2012



Professor of Pediatrics

Tufts Medical Center

Boston, Massachusetts

Term:  07/01/2008 - 06/30/2012


NEUZIL, Kathleen, M.D., M.P.H. 

Senior Clinical Advisor, PATH  

Clinical Associate Professor of Medicine, University of Washington 

Seattle, Washington

Term: 07/01/06-06/30/10


SAWYER, Mark H., M.D.

Professor of Clinical Pediatrics

Division of Pediatric Infectious Disease

UCSD School of Medicine and Rady Children's Hospital San Diego

Medical Director, San Diego Immunization Partnership

San Diego County HHSA Immunization Branch

San Diego, California

Term: 04/23/08-06/30/09


SUMAYA, Ciro Valent, M.D., M.P.H.T.M.

Founding Dean and Cox Endowed Chair in Medicine  

School of Rural Public Health

Texas A&M Health Science Center

College Station, Texas  

Term: 07/01/06-06/30/10

TEMTE, Jonathan, M.D. Ph.D.

Associate Professor

Department of Family Medicine

University of Wisconsin School of Medicine and Public Health

Department of Family Medicine

Madison, Wisconsin

Term: 04/22/08-06/30/11


Ex Officio Members

Centers for Medicare and Medicaid Services (CMS)

MURPHY, Linda  


Senior Health Insurance Specialist  

Centers for Medicare & Medicaid Services  

Baltimore, Maryland


Department of Defense (DOD)  

HACHEY, Wayne, DO, M.P.H. 


Director, Preventive Medicine & Surveillance

Office of the Assistant Secretary of Defense Force Health Protection and Readiness

Falls Church, Virginia

CIESLAK, Theodore (Ted), M.D. 

Col, MC 

Defense Department Liaison Officer  

Centers for Disease Control and Prevention 

Atlanta, Georgia


Department of Veterans Affairs (DVA)

Linda S. Kinsinger, MD, MPH

Chief Consultant for Preventive Medicine

Office of Patient Care Services

National Center for Health Promotion and Disease Prevention

Durham, North Carolina


Food and Drug Administration (FDA)

BAYLOR, Norman, Ph.D.


Office of Vaccines Research Review 

Rockville, Maryland


(and more)


This document can be found on the CDC website at:


Generation Rescue’s Independent California-Oregon Vaccine Survey – More Autism, More ADHD, More Neurological Disorders

(link to full report)

Our Press Release here:

A report from UPI here:

Congresswoman Carolyn Maloney (D-NY) - "Generation Rescue's study is impressive and forcefully raises some serious questions about the relationship between vaccines and autism. What is ultimately needed to resolve this issue one way or the other is a comprehensive national study of vaccinated and unvaccinated children," said Congresswoman Maloney. "The parents, doctors and scientists behind Generation Rescue only want information. They deserve more than road blocks, they deserve answers. We can and should move forward in search of those answers. That's why I've introduced a common sense bill that would require the National Institutes of Health (NIH) to conduct a comprehensive, comparative study…”



Generation Rescue commissioned an independent opinion research firm, SurveyUSA of Verona NJ, to conduct a telephone survey in nine counties in California and Oregon. Interviews were successfully completed in 11,817 households with one or more children age 4 to 17. From those 11,817 households, data on 17,674 children was gathered. Of the 17,674 children inventoried, 991 were described as being completely unvaccinated. For each unvaccinated child, a health battery was administered.

Generation Rescue chose to use telephone interviews with parents to gather data on children, so as to closely mirror the methodology the CDC uses to establish national prevalence for NDs such as ADHD and autism through their national phone survey of parent responses. Generation Rescue chose to focus on children ages 4-17 to match the age range used by CDC.

Are parent responses a reliable indicator of a child's diagnostic status? According to Dr. Laura Schieve, co-author of the CDC's national phone survey study, in discussing the CDC's two phone surveys on autism prevalence, "the consistency of prevalence estimates across the two surveys supports high reliability or reproducibility of parental report of autism and reliability is one important component of validity."

SurveyUSA is a well-known national opinion research firm with unique expertise in canvassing local communities. SurveyUSA has no vested interest in any outcome this or any survey might produce. You can see a copy of the questionnaire used in the survey here. The data the survey intended to capture included:

- Households with a child or children aged 4-17

- Whether or not that child had been vaccinated

- Whether or not that child had any one (or more) of the following diagnosis: ADD, ADHD, Asperger's, PDD-NOS, Autism, Asthma, or Juvenile Diabetes (the final two of which were added to consider other health outcomes).

The results of the survey allowed us to compare the prevalence (what percentage of children have a particular diagnosis) to see if there was any meaningful difference between unvaccinated and vaccinated children.

The most common way to measure prevalence differences is through a calculation known as relative risk or the Risk Ratio, where we compared prevalence amongst unvaccinated children to prevalence amongst vaccinated children. So, if 5% of unvaccinated children have asthma, and 10% of vaccinated children have asthma, that represents an "RR" of 2.0 (10%/5%), or a difference of 100%. We were also able to look at the data by gender, age, and county.


SurveyUSA gathered data on 9,175 boys and 8,499 girls

·   After thousands of reports of children regressing into autism after receiving their childhood vaccines, Generation Rescue conducted this independent survey of 17,674 children of which 991 were unvaccinated.

·   Vaccinated individuals were reported to be :

a. 155% more likely to have neurological disorders

b.224% more likely to have ADHD

c. 61% more likely to have autism

·   To date, no one else has ever studied the vaccinated and unvaccinated community looking for neurological outcomes.


Generation Rescue is not representing that our study definitively proves that the U.S. vaccine schedule has caused an epidemic in neurological disorders amongst our children. That said, for less than $200,000, we were able to complete a study that the CDC, with an $8 billion a year budget, has been unable or unwilling to do. We think the results of our survey lend credibility to the urgent need to do a larger scale study to compare vaccinated and unvaccinated children for neurodevelopmental and chronic illness outcomes.


They call our community Anti-Vaccine – It is not true.

We are NOT anti-vaccine


a. We ARE anti-schedule.  We know our schedule is too bloated and want to only vaccinate for the most serious diseases. 


b.  We want to go back to the 1983 schedule + HIB, since autism was 1 in 10,000 then, or use the Sweden, Denmark , or Japan Vaccine schedule which also only use 11 vaccines and those countries have a much lower under 5 year old mortality rate.


2.)   We ARE anti-toxin. 

a. Most of the 35 vaccines ingredients do not have positive safety studies. 

b.   We are concerned about the Aluminum, formaldehyde, MSG, diseased monkey cells, mercury and other ingredients that are toxins and have not been properly safety tested.


1.   Through extensive scientific study, has been shown to be neurotoxin (kills brain cells), is linked to Alzheimer’s, and cancer.

2.   There are 19 Studies About Aluminum Toxicity on our website at:


3.   Aluminum is delivered at a very high rate in vaccines and is above EPA levels for adults during any typical pediatric vaccine visit and above safety levels just by vaccination with the DTaP or MMR vaccines.



Calculating Aluminum in Vaccines

Here are the current levels of aluminum per shot of the following vaccines, as listed on the packaging of each vaccine:

* HIB - PedVax – 225 mcg Aluminum

* PC (Pneumococcal) Vaccine – 125 mcg Aluminum

* DTaP – Taptacel Brand (Sanofi Pasteur) – 330 mcg Aluminum

* DTaP – Tripedia Brand (Sanofi Pasteur) – 170 mcg Aluminum

* DTap – Infanrix Brand (GlaxoSMithKline) – 625 mcg Aluminum

* DT (Sanofi Pasteur) – 170 mcg Aluminum

* dT – Decavac (Sanofi Pasteur) – 280 mcg Aluminum

* Heb P – Recombivax (Merck) – 250 mcg Aluminum

* Hep B – Engerix-B (GlaxoSMithKline) – 250 mcg Aluminum

* Hepatitis A – 250 mcg Aluminum

* HPV – Gardasil – 225 mcg Aluminum

Combination Vaccines

* Comvax (hep B and HIB) – 225 mcg Aluminum

* Pentacel (DTaP, HIB and Polio) – 330 mcg Aluminum

In other words, a newborn who gets a Hepatitis B injection on day one of life would receive 250 mcg of aluminum. This would be repeated at one month with the next Hep B shot. When, at two months, a baby gets its first big round of shots, the total dose of aluminum could vary from 295 mcg (if a non-aluminum HIB and the lowest-aluminum brand of DTaP are used) to a whopping 1225 mcg (if the Hep B vaccine is given along with the brands with the highest aluminum contents). These doses are repeated at four and six months. With most subsequent rounds of shots, a child would continue to get some aluminum throughout the first two years. But the FDA recommends that premature babies, and anyone with impaired kidney function, receive no more than 10 to 25 mcg of injected aluminum at any one time.

Sources: Dr. David Ayoub and The Vaccine Book by Dr. Bob Sears


is a cancer-causing agent and is in most vaccines.



is still in several flu vaccines (25 mcg of mercury) and several other vaccines in trace amounts.  Trace amounts are above the toxic standards for water. The EPA recommended daily exposure:  .4 mcg



Vaccines are not safety tested for cancer or DNA altering effects (mutanegenic effects), even though they have cancer-causing (carcinogenic) ingredients and mutated viruses in them.

1.)   Most Manufacturer Vaccine Information Sheets (VIS) Say, [vaccine name] vaccine has not been evaluated for carcinogenic [cancer causing] or mutanegenic [DNA altering] potential or impairment of fertility

a. Studies show that heavy metals can trigger life-long chronic illness.

“Epigenetic fetal programming via DNA methylation may provide a pathway by which environmental lead exposure can influence disease susceptibility.”

b.   A summary of vaccine ingredients, side effects and evidence of lack of safety testing is available at.


Evidence of the Causes of Autism, the Injury Vaccines can Cause and Science Based Treatment Approaches


About Generation Rescue

Common Autism Facts and Statistics

Autism is on the Rise

Autism is a physical illness and is treatable

Autism And Vaccines – A Major Contributing Factor of Toxins and Infections

Pediatric Vaccine Ingredients and Published Possible Side Effects

The “14 Studies” commonly quoted in the press are corrupt

The medical establishment agrees that the children with autism are ill but does not offer treatments based on the scientific evidence

AAP and The Mercury Smoke Screen – Today

The Center of Disease Control Receives Funds Based On Vaccine Sales

Parent are Not Being Given Informed Consent

Vaccine Court Cases – Vaccines Can Trigger Autism, 13 Times

It’s not Easy to Get Vaccine Witnesses for Vaccine Court

Dr. Bernadine Healy, Former Director of the National Institutes of Health

Other Mainstream Voices Concerned About Vaccines and are For Vaccine Research

Deadly Immunity - By Robert F. Kennedy Jr.


Next -> Pediatric Vaccine Ingredients and Published Possible Side Effects